Motley Fool Money

Stephanie Marini, a Certified Financial Planner who helps people organize cash flow and debt, shares practical steps to automate payments and savings. She walks through tracking 30 days of spending, choosing a debt-payoff strategy that motivates you, and building tiered sinking funds. Short, actionable advice to tackle the financial task you've been avoiding.

Jon Quast, Motley Fool analyst known for tech stock picks, and Lou Whiteman, investment analyst focused on tech and consumer markets. They tackle big tech’s $650 billion AI capex shock. They debate who wins in the supply chain, whether massive AI spending makes economic sense, and which software and restaurant names might be vulnerable or attractive.

Jon Quast, market analyst focused on AI infrastructure and cybersecurity, and Matt Frankel, long-term stock analyst who emphasizes valuation and durability. They unpack Anthropic’s Claude Cowork shock to software stocks. They compare this to DeepSeek, sort software by AI risk, highlight cybersecurity and infrastructure winners, and discuss recent tech layoffs and macro impacts on investing.

Rachel Warren, Motley Fool analyst who covers consumer and pharma, and Lou Whiteman, Motley Fool analyst focused on media and consumer trends, discuss Disney’s leadership change and what Josh D’Amaro’s parks background could mean for the company. They also cover Chipotle’s softening traffic and margins. The conversation touches on GLP-1 competition and differing prospects for Novo Nordisk and Eli Lilly.

Loren Hurst, Fool analyst focused on fintech and consumer tech. Jason Hall, Fool analyst covering technology and gaming companies. They unpack PayPal’s surprise CEO change and its valuation debate. They dig into Google’s Project Genie and the idea of prompt-to-play. They explore AI’s impact on game creation and Roblox’s premium ad push.

Tom King, Rule Breakers analyst who tracks earnings and market trends, and Karl Thiel, biotech-focused analyst who follows drug approvals and FDA shifts. They dig into biotech’s 2025 outperformance versus AI, turmoil and political pressure at the FDA, investment risk and longer timelines for gene and cell therapies, and previews for Lilly, Novo Nordisk, and Twist Bioscience results.

Oleg Vornik, CEO of DroneShield, leads an Australian defense tech firm that builds counter-drone hardware and software. He discusses detection and jamming technology and early deployments to military and civilian customers. He describes battlefield use in Ukraine and threats to data centers, stadiums, airports, energy sites, and prisons.

Dan Caplinger, Motley Fool contributor and former financial planner, shares decades of retirement planning experience. They discuss the emotional uncertainty of stopping work. They talk spreadsheets and calculators used to validate plans. They cover healthcare before Medicare, phased transitions versus full retirement, and preparing socially for life after work.

Emily Flippen, Motley Fool tech and AI analyst, and Lou Whiteman, long-term markets and company analyst, debate Elon Musk’s reported SpaceX–xAI tie-up. They dive into pre-IPO strategy, intercompany funding dynamics, big tech earnings, Google’s Chrome AI move, and a tour of beaten-down SaaS names and notable stock picks.

Jon Quast, Motley Fool analyst focusing on sector winners and corporate strategy. Matt Frankel, longtime Motley Fool investment analyst with stock and financial expertise. They dive into Tesla’s pivot toward autonomy and humanoid robots and the Model S/X production halt. They also tackle Meta’s huge capex plan, Microsoft’s OpenAI ties, and which industrial and AI-infrastructure stocks are catching attention.